Retail Asia13/04/2017
4min0
Hong Leong Investment Bank (HLIB) Research is maintaining its Sell rating on Pharmaniaga and target price of RM4.29, based on FY18 price-to-earnings multiples of 15.6 times , which is in line with the international peers. It said on Thursday that despite Pharmaniaga’s monopoly in the government concession business, “we expect near term headwinds driven by […]